Presentation to the Committee on Assessment of Agent-Based Models to Inform Tobacco Product Regulation
|
|
- Doreen Dawson
- 5 years ago
- Views:
Transcription
1 Presentation to the Committee on Assessment of Agent-Based Models to Inform Tobacco Product Regulation This work was funded by the U.S. Food and Drug Administration (FDA) through a contract with the U.S. Department of Energy/Sandia National Laboratories. The information included in this presentation reflects the views of the authors and should not be construed to represent FDA s positions or policies. Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy s National Nuclear Security Administration under contract DE-AC04-94AL85000.
2 Presentation Outline Introduction Agent-Based Modeling Lessons Learned SnapDragon Conceptual Model Model Development and Verification Model Verification and Validation Process Next Steps 2
3 Agent-Based Modeling A computer-based modeling approach, often associated with modeling complex systems Agents Can be individuals, groups, organizations, or other system components Are often part of a network Rules (typically simple rules) determine agent interaction and agent behavior Agents act and interact in the system Agents/nodes are joined by links on a directed network Arrows indicate nomination, influence flows in the opposite direction 3
4 Utility of Agent-Based Models (ABMs) Useful when there is no equation for an emergent behavior Explains system behavior using lower-level dynamics. Generate the behavior of interest: agents act based on lower-level rules, community behavior emerges Lower-level assumptions, perhaps coming from a variety of domains, can be analyzed Perturbations (e.g., policies/interventions) are introduced, agent actions can cascade into changes at higher levels of the system Useful for analysis of conditions not seen before Useful for representing heterogeneity - Agent-based modeling is more useful for tracking multiple individual attributes Agent-based models (ABMs), as well as other models, Are abstract representations Are not crystal balls Provide an in-silico workbench/ quantitative exploratory testbed on which policy comparisons can be conducted 4
5 Regulatory Context The Family Smoking Prevention and Tobacco Control Act (FSPTCA), signed into law by President Barack Obama on June 22, 2009: Recognizes the FDA as the primary Federal regulatory authority with respect to the manufacture, marketing, and distribution of tobacco products FSPTCA authorizes the FDA to: Require disclosure of tobacco product ingredients Require stronger health warnings on packaging and in advertisements Create standards for tobacco products Restrict tobacco sales, distribution, and marketing Mandates regulatory decisions be based on the protection of public health, which shall be determined with respect to the risks and benefits to the population as a whole, including users and nonusers of the tobacco product 5
6 Social Network Analysis for Policy on Directed Graph Networks (SnapDragon) SnapDragon: An agent-based model Represents individuals (or other system components) within a social network Desired Model Functionality Provides prevalences for specified products (characterized by properties) and conditions Allows identification/comparison of impacts of policies and policy combinations Informs population health models (changes in initiation and cessation rate, product transition distributions) Integrates multiple aspects of theory, policy and data 6
7 Lessons Learned from Modeling for Health and Regulatory Analyses Public health Pandemic modeling (beginning in 2005) Zoonotic (Afghan) Medical facilities Hepatitis C, Legionella, Varicella Food supply chains Regulatory Nuclear Waste Disposal Compliance Assessments Nuclear Energy Safety Chemical Facilities 7
8 Lessons Learned When to use Models Future time frame, new conditions, regulatory impacts difficult to foresee Data limited or ambiguous Can t experiment in advance Modeling for Policy Multiple modeling approaches Don t over-constrain problem boundaries Agent-Based Models Emergent behavior in response to interactions Conditions not seen before Heterogeneity - Agent-based modeling is more useful for tracking multiple individual attributes Relatively easy to verify, more difficult to validate 8
9 Lessons Learned: Synthesized in Process Conceptual Model Development Define system and boundaries Identify model requirements Existing models; Relevant models, draw from information disciplines Develop model(s) Keep simple as possible Build and test incrementally Build confidence in model structure and results Re-evaluate model as system changes, or as data are collected 9
10 Stages of Model Development and Use Required confidence depends on use of the model Greater output fidelity possible as model matures Different uses in different stages of development Stage Conceptual Exploration Explanation Level of Confidence Minimal Low Medium Utility Problem Framing Hypothesis Formulation Develop Intuition Hypothesis Testing Evaluating trade-offs Screening options Confirmation High Inform high-consequence decisions 10
11 Our Clearly Posed Problem FSPTCA: Regulatory decisions to be based on the protection of public health, which shall be determined with respect to the risks and benefits to the population as a whole, including users and nonusers of the tobacco product 11
12 Conceptual Model Development Entities and Relationships Building the Big Picture 12
13 Problem Space: Tobacco Use Dynamics Population Non-Users Tobacco Users Morbidity Mortality Social Norms Former Users 13
14 Tobacco Use Dynamics Tobacco Control Community Public Health Advocacy Research Lobbying CDC, NGOs, Other International PH Advertising & Education Morbidity Mortality Social Norms Population Non-Users Tobacco Users Former Users HHS/FDA/CTP Treasury/ATF/TTB State Governments Local Governments Tobacco Regulation 14
15 Tobacco Use Dynamics Tobacco Control Community Tobacco Product Retailers Manufacturers of Tobacco Products Public Health Advocacy Research Lobbying CDC, NGOs, Other International Population Non-Users Tobacco Users Product Importing Tobacco Product Advertising & Marketing Product Research Production and Distribution PH Advertising & Education Morbidity Public Relations & Proxies Mortality Social Norms Former Users Tobacco Products Lobbying Tobacco Growers US Agriculture Imported Tobacco Tobacco Lobbying HHS/FDA/CTP Treasury/ATF/TTB State Governments Local Governments Tobacco Regulation 15
16 Tobacco Control Community Public Health Advocacy Research Lobbying CDC, NGOs, Other International PH Advertising & Education Morbidity Mortality Social Norms Population Non-Users Tobacco Use Dynamics Tobacco Users Former Users Tobacco Product Retailers Product Importing Manufacturers of Tobacco Products Tobacco Product Advertising & Marketing Product Research Production and Distribution Public Relations & Proxies Tobacco Products Lobbying Tobacco Growers US Agriculture Imported Tobacco Tobacco Lobbying HHS/FDA/CTP Treasury/ATF/TTB State Governments Local Governments Tobacco Regulation US Congress State Legislatures City Councils Legislation Supreme Courts Appellate Courts District Courts (Federal or State) Judicial 16
17 Tobacco Control Community Public Health Advocacy Research Lobbying CDC, NGOs, Other International PH Advertising & Education Morbidity Mortality Social Norms Population Non-Users Tobacco Use Dynamics Tobacco Users Former Users Tobacco Product Retailers Product Importing Manufacturers of Tobacco Products Tobacco Product Advertising & Marketing Product Research Production and Distribution Public Relations & Proxies Tobacco Products Lobbying Tobacco Growers US Agriculture Imported Tobacco Tobacco Lobbying Finance Stock Markets Commodity Markets HHS/FDA/CTP Treasury/ATF/TTB State Governments Local Governments Tobacco Regulation US Congress State Legislatures City Councils Legislation Supreme Courts Appellate Courts District Courts (Federal or State) Judicial 17
18 Tobacco Control Community Public Health Advocacy Research Lobbying CDC, NGOs, Other International PH Advertising & Education Morbidity Mortality Social Norms Population Non-Users Tobacco Use Dynamics Tobacco Users Former Users Tobacco Product Retailers Product Importing Manufacturers of Tobacco Products Tobacco Product Advertising & Marketing Product Research Production and Distribution Public Relations & Proxies Tobacco Products Lobbying Pharmaceuticals Nicotine Products as Quitting Aids Other (Nicotine Devices) Pharma Advertising & Marketing Treatment & Cessation Tobacco Growers US Agriculture Imported Tobacco Tobacco Lobbying Finance Stock Markets Commodity Markets Supreme Courts Treatment of Individuals Appellate Courts Research Health Care Health Life Liability HHS/FDA/CTP Treasury/ATF/TTB State Governments US Congress State Legislatures City Councils District Courts (Federal or State) Judicial Insurance Local Governments Tobacco Regulation Legislation 18
19 Tobacco Control Community Public Health Advocacy Research Lobbying CDC, NGOs, Other International PH Advertising & Education Morbidity Mortality Social Norms Population Non-Users Tobacco Use Dynamics Tobacco Users Former Users Tobacco Product Retailers Tobacco Products Product Importing Tobacco Products Manufacturers of Tobacco Products Tobacco Product Advertising & Marketing Product Research Production and Distribution Public Relations & Proxies Tobacco Products Lobbying Pharmaceuticals Nicotine Products as Quitting Aids Other (Nicotine Devices) Pharma Advertising & Marketing Treatment & Cessation Tobacco Growers US Agriculture Imported Tobacco Tobacco Lobbying Tobacco Leaves Finance Stock Markets Commodity Markets Supreme Courts Treatment of Individuals Appellate Courts Research Health Care Health Life Liability HHS/FDA/CTP Treasury/ATF/TTB State Governments US Congress State Legislatures City Councils District Courts (Federal or State) Judicial Insurance Local Governments Tobacco Regulation Legislation Arrows show flow of: Tobacco 19
20 Tobacco Control Community Public Health Advocacy Research Lobbying CDC, NGOs, Other International PH Advertising & Education Morbidity Mortality Social Norms Population Non-Users Tobacco Use Dynamics Tobacco Users Former Users Tobacco Product Retailers Tobacco Products Product Importing Tobacco Products Manufacturers of Tobacco Products Tobacco Product Advertising & Marketing Product Research Production and Distribution Public Relations & Proxies Tobacco Products Lobbying Pharmaceuticals Nicotine Products as Quitting Aids Other (Nicotine Devices) Pharma Advertising & Marketing Treatment & Cessation Quitting Aids Treatment Tobacco Growers US Agriculture Imported Tobacco Tobacco Lobbying Finance Stock Markets Commodity Markets Supreme Courts Treatment of Individuals Appellate Courts Pharmaceuticals Research Health Care Health Life Liability HHS/FDA/CTP Treasury/ATF/TTB State Governments US Congress State Legislatures City Councils District Courts (Federal or State) Judicial Insurance Local Governments Tobacco Regulation Legislation Arrows show flow of: Tobacco Goods 20
21 Tobacco Control Community Public Health Advocacy Research Lobbying CDC, NGOs, Other International PH Advertising & Education Education & Warnings Pharmaceuticals Nicotine Products as Quitting Aids Other (Nicotine Devices) Pharma Advertising & Marketing Treatment & Cessation Morbidity Mortality Social Norms Population Non-Users Quitting Aids Tobacco Use Dynamics Tobacco Users Former Users Warnings Treatment Tobacco Product Retailers Product Importing Tobacco Tobacco Products Products Advertisements Content, Information Access & Age Limits Tobacco Product Standards Manufacturers of Tobacco Products Tobacco Growers US Agriculture Imported Tobacco Tobacco Lobbying Tobacco Product Advertising & Marketing Trade Agreements Product Research Production and Distribution Public Relations & Proxies Tobacco Products Lobbying Tobacco Leaves Data, Applications Finance Stock Markets Commodity Markets Legal Ruling Stock Price Economic Pressure (indicators) Treatment of Individuals Political Pressure Supreme Courts Appellate Courts Pharmaceuticals Research Health Care Tax $$ Health Life Liability Insurance HHS/FDA/CTP Treasury/ATF/TTB State Governments Local Governments Tobacco Regulation Legal Guidance Laws Data US Congress State Legislatures City Councils Legislation Legal Reading District Courts (Federal or State) Judicial Political Pressure (Campaign Contributions $$) Arrows show flow of: Tobacco Goods Data Data / Info Political Pressure Information 21
22 Connections between Tobacco Entities Tobacco Control Community Public Health Advocacy Research Lobbying CDC, NGOs, Other International PH Advertising & Education $$ Pharmaceuticals Nicotine Products as Quitting Aids Other (Nicotine Devices) Pharma Advertising & Marketing Treatment & Cessation Pharmaceuticals Education & Warnings Treatment of Individuals Research $$ Health Care Tax $$ Morbidity Mortality Social Norms Population Non-Users Quitting Aids $$ Payments Tobacco Users Former Users Warnings Treatment Health Life Liability $$ Insurance $$ Tobacco Product Retailers Product Importing Tobacco Tobacco Products Products Advertisements Content, Information Access & Age Limits HHS/FDA/CTP Treasury/ATF/TTB State Governments Local Governments $$ Tobacco Product Standards Manufacturers of Tobacco Products Tobacco Growers Tobacco Regulation US Agriculture Imported Tobacco Tobacco Lobbying Political Pressure Tobacco Product Advertising & Marketing Trade Agreements Legal Guidance $$ Laws Data Product Research Production and Distribution Public Relations & Proxies Tobacco Products Lobbying $$ Tobacco Leaves Tax $$, Fine $$ US Congress State Legislatures City Councils Legislation Tax $$ Data, Applications Finance Stock Markets Commodity Markets Data Legal Reading Data / Info Political Pressure Legal Ruling Stock Price Economic Pressure (indicators) Supreme Courts Appellate Courts District Courts (Federal or State) Judicial Political Pressure (Campaign Contributions $$) Arrows show flow of: Tobacco Goods Information Money 22
23 Multiple Connected Feedback Loops Public Health Advocacy Research Lobbying CDC, NGOs, Other International PH Advertising & Education Education & Warnings Pharmaceuticals Research Pharmaceuticals $$ Nicotine products as quitting aids (patches, gum) Other (nicotine devices) Pharma advertising and marketing Others for treatment and cessation (antidepressants, nicotine vaccine, chemo, radiation sources) Health Care Non-Users Morbidity Mortality Treatment of Individuals Social Norms Public Health Cycle Tax $$ Quitting Aids $$ Population Payments Tobacco Users Former Users Warnings Treatment $$ Insurance Tobacco Product Retailers $$ Tobacco Products $$ Product Importing Tobacco Products Advertisements Content Information Access & Age Limits Tobacco Product Standards Tobacco Growers US Agriculture Imported Tobacco Tobacco Lobbying Regulations/ Legislative Cycle FDA Political Pressure Tobacco Product Regulation Tobacco Product Manufacturers Tobacco Product Advertising and Marketing Product Research Labor Production and Distribution (legal and illegal) Public Relations & Proxies Products Tobacco Products Lobbying Trade Agreements Legal Guidance $$ Laws Data Tobacco Leaves $$ Tax $$, Fine $$ Federal State Local Legislation Tax $$ Money Advertising Data, Applications Finance Stock Markets Commodity Markets Legal Interpretation Data Economic Pressure (indicators) Data / Info Political Pressure Legal Ruling Stock Price Judicial Political Pressure (Campaign Contributions $$) Arrows show flow of: Tobacco Goods Information Money 23
24 Model Purview Public Health Cycle Regulatory Cycle 24
25 Social Influence and Information Flow The evidence is sufficient to conclude that there is a causal relationship between peer group social influences and the initiation and maintenance of smoking behaviors during adolescence. - Preventing Tobacco Use Among Youth and Young Adults, A Report of the Surgeon General,
26 Conceptual Model Development We are here 26
27 Multiple Modeling Approach Existing models examine essential components of the system Population models (macro-level e.g., Nation, State): Project future population health states, use historical and hypothesized changes in initiation and cessation rates Agent-based models that examine specific issues (reactance, points of sale) SnapDragon is useful for examining the use of tobacco products as an emergent behavior due to changes in products and regulations 27
28 SnapDragon Model Goals Comparative analysis of policy option impacts on individual/group initiation and cessation behaviors Inform population health models - changes in initiation and cessation rate, product transition distributions Explore a future that may be very different from the past Evolving market / new products New/evolving regulatory environment 28
29 SnapDragon Conceptual Model SnapDragon Conceptual Model 29
30 Key Model Elements Population of individuals Tobacco products and their attributes Regulations and interventions that limit access to tobacco products and their use, facilitate quitting assistance (quit lines, aids) Information about tobacco products (marketing and risk) Peer/family/social influence Individual differences (risk takers, adults, youth, role models, addiction) Tobacco use Tobacco Products Information Individuality Regulations Family/Friends 30
31 Model Tobacco-Related Influences Model Requirement Represent individuals integrated view of tobacco Represent influences and propagate changes in individual views Model Representation Opinion variable Opinion Dynamics High school seniors social network (From: Variations in network boundary and type: A study of adolescent peer influences, Thomas W. Valente et al., [in press: Social Networks, an international journal of structural analysis]) 31
32 Opinion An Integrated View of a Product Opinion variable represents: Integrated view of a product The result of multiple influences and perceptions Range 0 (lowest opinion of a product) 1 (highest opinion of a product) 32
33 Positive Negative Opinion: Integrated View of Tobacco Social Influences (Affect) Sophisticated Cool Group identity Adult Independence Déclassé Smell/taste Corporate Practical Influences (Perceived Utility) Stress relief Concentration Avoiding the effects of withdrawal Weight control Disease Addiction Dangers of Environmental Tobacco Smoke Positive Negative 33
34 Applications of Opinion Dynamics Models Opinion dynamics models of information spread have been demonstrated and validated in many domains Initially proposed in 1999 to model uptake of environmentally sustainable agricultural practices in Europe (Deffuant et al. 2000) Political opinions (Galam 2012) Political extremism and terrorism (Deffuant 2006, Amblard and Deffuant 2002) Gender-based social networks in tribal cultures (Moore et al. 2012) 34
35 Simplified Conceptual Diagram Family/Friends Individual Opinion Products Information 35
36 Simplified Conceptual Diagram Family/Friends Products Individual Opinion Individual Tobacco-Use Behavior Information 36
37 Simplified Conceptual Diagram Family/Friends Barriers to Access Products Individual Opinion Costs Addiction Risk Affinity Individual Tobacco-Use Behavior Information 37
38 SnapDragon Modeling Approach SnapDragon Modeling Approach 38
39 Simplified Modeling Approach Family/Friends Opinion Dynamics: An approach for the analysis of social influences on individual Individual opinions, the emergence Opinion of community-scale Products patterns Barriers to Access Costs Addiction Risk Affinity Individual Tobacco-Use Behavior Information 39
40 Simplified Modeling Approach Family/Friends Opinion Dynamics: An approach for the analysis of social influences on individual Individual opinions, the emergence Opinion of community-scale Products patterns Barriers to Access Costs Opinion-to-Behavior Mapping Addiction Risk Affinity Individual Tobacco-Use Behavior Information 40
41 Summary of SnapDragon Modeling Approach Model Purpose Assess changes in future prevalence Comparison of impacts, potential effects of policies and policy combinations Inform population models Inform regulatory design Model Requirements Based on system view and regulatory authorities Model Development Agent-based technique most suitable Emergent behavior in response to interactions Heterogeneity - Agent-based modeling is more useful for tracking multiple individual attributes Opinion dynamics describes movement of ideas on social networks Opinion-to-behavior mapping incorporates Regulatory components such as access, costs Individual characteristics, e.g., risk-taking, addiction 41
42 SnapDragon Modeling Approach We are here Model results are discussed in terms of tobacco use behaviors, consistent with model design. The scenarios presented are hypothetical and show model behavior. Results are not intended to represent a specific forecast. 42
43 Model Implementation Starting with Opinion Spread Use software agents to represent a population of individuals Each individual assigned two values to start: Opinion: Integrated view of the issue under study Tolerance: Degree of openness to consider other ideas At each time step, agents adjust their opinion based on opinions of neighboring agents and their own tolerance 43
44 Individual Opinion: Bounded-Confidence Formulation x i N ( t i 1) S i : x x k i ( t) ( t) 1 k x i N i [ x ik ( t) i k ( t) x i ( t)] Update Rule: Adjust individual agent s opinion by mean scaled opinion differences of opinion and neighbors opinions within tolerance limits S i Tolerance (Do you influence i Plasticity (How much you influence i x Opinion (My integrated N i Set of ( t) Subset of k number of out degree S i neighbors neighbors view) me?) within tolerance within tolerance me) bounds at time t bounds 44
45 Opinion Model: Effect of Tolerance B B and C contribute to new opinion value for A D s opinion excluded since it is outside of tolerance A ε: Tolerance x: Opinion (integrated view of tobacco use) C D Directionality of arrows represents nominations (individuals nominate others as their friends) Influence flows in opposite direction (from the nominee to the individual) 45
46 Opinion Model: Effect of Plasticity and Tolerance At each step, the new opinion is original value plus mean residual scaled by plasticity B D C A A D B C µ: Plasticity ε: Tolerance 46
47 Opinion Model: Information Effects Information sources modeled as social network nodes broadcasting messages to individuals Pro-tobacco information sources represented as highopinion messages, values closer to 1.0 A B Media Node D 0.1 for all Public-health information sources represented as lowopinion messages, values closer to 0.0 C 47
48 Opinion Model: Information Effects Due to tolerance and changes in opinion: B D C A Media the Media node primarily impacts Agent B s opinion Agent A s opinion continues to be influenced by those of Agent B and Agent C B A D C 48
49 Opinion Model: Default Parameter Values Networks ER graphs (directed random graphs with a Poisson degree distribution) 250 nodes Probability of connection of Initial Agent Opinion Distribution (uniform 0-1) Tolerance 0.21 Plasticity 0.05 Note: See Table 1 in the manuscript An Opinion-Driven Behavioral Dynamics Model for Addictive Behaviors for a complete list of parameter default values, ranges and explanations 49
50 Agents SnapDragon Behavior: Media Broadcast Impact on Average Opinion Media Node Broadcast opinion sweep [0-1] Default values for all other parameters 10,000 runs 250-agent network 2.5 million agents total 50
51 Media Broadcast Impact on Individual Opinion 51
52 Mapping of Opinion to Behavior: Smoking If the agent s opinion about smoking is greater than threshold, the agent is a smoker The higher the initiation threshold the greater the barriers to the behavior The initiation threshold can be age dependent Initiation Threshold Opinion of Smoking Smoker. x 0 52
53 Mapping of Opinion to Behavior: Addiction Because of addiction, behavior is path dependent Non-Smoker Cessation Threshold Initiation Threshold The effect of addiction is represented with a cessation threshold A smokers opinion must fall below cessation threshold to overcome addiction Opinion of Smoking Smoker 53
54 Mapping of Opinion to Behavior: Addiction Factor Cessation Threshold Initiation Threshold The addiction factor is the difference between the initiation and cessation thresholds Non-Smoker D x Smoker Addiction Factor 54
55 Examine: Cessation Support Effect on Prevalence Effect of cessation support modeled as an increase in the Cessation Threshold Non-Smoker New Cessation Threshold Initiation Threshold Result - agents become former-smokers at a higher opinion value D x Smoker Addiction Factor 55
56 Testing Impact of Cessation Threshold on Modeled Prevalence Addiction Factor = 0 Cessation Threshold = Initiation Threshold Implications: If cessation support helps overcome addiction, then the model implementation of raising the Cessation Threshold value is appropriate Model behaves as designed for the full range of Cessation Threshold values 56
57 Cessation Threshold Impact on Modeled Prevalence Heat map shows the range of input where simulated prevalence is reduced 57
58 Combined Effects of Cessation Threshold and Messaging No messaging Public Health messaging Public Health and Pro-Smoking messaging Increasing the Cessation Threshold can reduce modeled prevalence Simulated prevalence reduction is enhanced with a low broadcast opinion Hypothetical public health message scenario (Broadcast Opinion = 0.35) With high and low broadcast opinions active, a larger increase in the Cessation Threshold is required before prevalence is reduced Hypothetical multi-messaging scenario (Broadcast Opinions = 0.75 and 0.35) 58
59 Representing Interventions Examples Intervention Model or Parameter Change Provide cessation support Decrease access through indoor air laws, age limits, or taxes and enforce regulations Increase risk awareness Raise the cessation threshold Raise the initiation threshold for specified age group or population Add education node(s) 59
60 Next Phase: Modeling Multiple Products Representing product switching and alternate product uptake Add risk affinity attribute for individual agents Represent product-specific risk perception as a distinct component of opinion 2-product model that has product switching and dual use 60
61 Modeling Multiple Tobacco Products: Risk Affinity Effect Risk Affinity Effect Decreases the range of opinion values under which the agent is a non-user Non-User User Increases the range of opinion values under which the agent is a user Cessation Threshold Initiation Threshold Opinion of Product Initiate product if: Opinion Risk Perception > Initiation threshold Risk Affinity Quit product if: Opinion Risk Perception < Cessation threshold Risk Affinity 61
62 Examine Potential Prevalence of Different Products Compare model behavior Run single-product model for cigarettes and then for the alternate product Examine effects of risk affinity and risk perception on model behavior 62
63 Effect of Perceived Risk, Risk Affinity and Broadcast Opinion on Modeled Prevalence Lower perceived risk increases modeled prevalence for the same ranges of risk affinity and broadcast opinion (greater volume under the surface) The effectiveness of broadcast opinion is altered by the combined effects of perceived risks and risk affinity 63
64 Modeling Product Switching Add switching behavior for addicted smokers with opinion below the smoking threshold Quits smoking Non-Smoker May switch from smoker to user of alternative product Does not switch, continues to smoke Smoker Cessation Threshold Risk Affinity Initiation Threshold Risk Affinity Opinion of Cigarettes Switch when: opinion product2 - risk perception product2 + (initiation threshold cig - opinion cig - risk perception cig ) > cessation threshold cig - risk affinity 64
65 Modeling Two Products: Possible Agent Behaviors Nonsmoker Smoker Nonsmoker Smoker CT-RA IT-RA 0 Cigarette Opinion 1 CT-RA: Cessation Threshold less Risk Affinity IT-RA: Initiation Threshold less Risk Affinity 65
66 Alternate -Product Opinion Modeling Two Products: Possible Agent Behaviors 1 Independent product use can result in dual use Nonsmoker/User Smoker/User IT- RA CT-RA Nonsmoker / Nonuser Smoker/ Nonuser 0 CT-RA IT-RA 0 Cigarette Opinion 1 CT-RA: Cessation Threshold less Risk Affinity IT-RA: Initiation Threshold less Risk Affinity 66
67 Alternate -Product Opinion Modeling Two Products: Possible Agent Behaviors Independent product use can result in dual use 1 Nonsmoker/User Smoker/User Nonsmoker/User Smoker/User IT- RA Nonsmoker/User Nonsmoker/Nonuser Smoker/User Smoker/Nonuser CT-RA Nonsmoker / Nonuser Smoker/ Nonuser 0 CT-RA IT-RA 0 Cigarette Opinion 1 CT-RA: Cessation Threshold less Risk Affinity IT-RA: Initiation Threshold less Risk Affinity 67
68 Alternate -Product Opinion Modeling Two Products: Possible Agent Behaviors Independent product use can result in dual use 1 Nonsmoker/User Smoker/User Nonsmoker/User Smoker/User IT- RA Nonsmoker/User Nonsmoker/Nonuser Smoker/User Smoker/Nonuser Nonsmoker/User Nonsmoker/Nonuser Smoker/User Smoker/Nonuser CT-RA Nonsmoker / Nonuser Smoker/ Nonuser 0 CT-RA IT-RA 0 Cigarette Opinion 1 CT-RA: Cessation Threshold less Risk Affinity IT-RA: Initiation Threshold less Risk Affinity 68
69 Alternate -Product Opinion Modeling Two Products: Possible Agent Behaviors Independent product use can result in dual use 1 Nonsmoker/User Smoker/User Nonsmoker/User Smoker/User IT- RA Nonsmoker/User Nonsmoker/Nonuser Smoker/User Smoker/Nonuser Nonsmoker/User Nonsmoker/Nonuser Smoker/User Smoker/Nonuser CT-RA 0 Nonsmoker / Nonuser CT-RA Smoker/Nonuser Nonsmoker/User (only due to switching) Nonsmoker/Nonuser IT-RA Smoker/ Nonuser 0 Cigarette Opinion 1 CT-RA: Cessation Threshold less Risk Affinity IT-RA: Initiation Threshold less Risk Affinity 69
70 Multi-Product Model Development Status Model Testing Underway Parameter sweeps to examine model behavior compared to single product model Next steps in verification testing include: Sensitivity Analysis Evaluating switching assumptions Progression from alternate product to cigarettes and additional dual use Validation Long-term goals Provide distributions for product-transition probabilities for population health models for different demographic and tobacco-use groups Provide distributions for product-specific initiation and cessation rates as necessary for demographic groups 70
71 Summary SnapDragon is an opinion-driven behavior dynamics model that provides the capability to: Explore single and multi-product environments and their effect on prevalence Explore interventions The model development process is incremental Additional capability is added only as needed and is kept simple to maintain model utility Verification tests and face validation are part of the development process 71
72 SnapDragon Verification and Validation Building Confidence in an Agent Based Model Iterative model development and testing 72
73 Characteristics of a Trusted Model Based on solid science Accepted theories Validated studies Well built Code is reliable Results are intuitive Final results corresponds to real-world examples 73
74 Processes that Build Confidence Verification Confirms model is correctly designed and implemented Applies Software Engineering processes to ensure quality Run the model with synthetic data sets to test functionality Validation Results correspond to real-world data Model assumptions are justified Rigor depends on intended use Uncertainty Analysis Identify sources of uncertainty and effects on model results Sensitivity Analysis determines response of output to inputs Uncertainty Quantification propagates uncertainties through model 74
75 SnapDragon Verification and Validation Status Stage Level of Confidence SnapDragon Status Processes Conceptual Minimal Advanced Documentation and Review Exploration Low Active Sensitivity Analysis, Verification Explanation Medium Initial Assumption Validation Confirmation High Future Validation 75
76 Model Verification Confirms model is correctly designed and implemented Software Engineering Process Professional design and coding standards Exhaustive testing of model outputs Unit tests Integration tests Regression tests Archive all code, executables, data inputs, model outputs, experimental designs for tracking and reproducibility Analyze Code Results Run the model in variety of scenarios Do results make sense? Is model running correctly over multiple trials? 76
77 Verification Early in Model Development Developers and analysts use SnapDragon to develop intuition and perform simple verification tests 77
78 Results of Large-Scale Verification Testing Confirmation of proper model functioning: Intended mathematics correctly transformed to code Software defects are detected early and fixed before causing harm Full documentation trail from code -> output -> interpretation Identifying outliers which may represent unintended consequences Sometimes the defects found aren t in the model code: Discovered the BA scale-free network algorithm in widely-used opensource network mathematics package was wrong. Replaced it with correct code Gold Standard sensitivity analysis method (Satelli s Variance Decomposition) found to be incorrect, correction of method published in
79 Validation: Which type of model? Output corresponds with real-world data Physics and engineering models: Well-defined mathematics and constraints Validation methods sophisticated and reliable Rigorous validation enables model-based prediction Models of populations and social processes: Includes complex social dynamics, humanin-the-loop, and data gaps Validation is challenging because of complexity and limited data Models often project tendencies and trends rather than exact outcomes 79
80 Agent-Based Model Validation Agent-based models are very challenging to validate Real-world data: fragmentary, contradictory or unavailable Emergence of group dynamics from agent interactions Validate agents and interactions Validate emergent large scale phenomena Agent-based modeling tradeoff: ABMs can tackle very difficult problems with little data Rigorous prediction-level validation often not feasible ABM Validation: Determine defensible probability distributions for outcomes from limited data and large uncertainties 80
81 Agent-Based Model Validation Methods Validate Assumptions Test each model assumption Basis for validating assumptions Accepted theory Previously validated studies Tests against real-world Sensitivity analysis showing effects of assumption on model Document assumptions, bases, and degree of confidence ID Assumption Basis N023 N024 N025 Normal distribution of edge weights Ignore edge reciprocity Directionality important Referenc e Confidenc e SA SAND Moderate SA EPJ High SA TBD High Compare Output with Real-World Data Accepted procedures to match distributions and trends of data sets Required statistical significance depends on intended use N026 Percolation at n/log(n) Theory TBD High 81
82 Determine sources of uncertainty and effect on model outputs Key to effective verification and validation Parametric Uncertainty Lack of knowledge about true values of inputs Input value ranges based on expert opinion or prior studies Stochastic Uncertainty Account for random nature of real-world SnapDragon stochastic components Social network topology Uncertainty Analysis Agents receiving media messages 82
83 SnapDragon Uncertainty Analysis Design experiment Start 10,000-run scenario Generate set of input parameters Repeat 100 times Repeat 100 times Create stochastic network, 250 nodes Model network tobacco prevalence Write results to output file End 10,000-run scenario Analyze data file Interpret results 83
84 Uncertainty Quantification Assign Probability Distributions of Inputs Calculate spread of possible outputs Model 84
85 SnapDragon UQ Example Uncertainty Quantification: propagate uncertain inputs through model to generate expected range of outputs CDF CDF Quantiles 85
86 Single-Factor Sensitivity Analysis Analyze effect of one uncertain input on output values Scatterplot shows effect of single input on output 86
87 Network Media Effect on Opinion and Tobacco Use Prevalence Mean Results Number of Runs Settings: 10,000 runs, 250-agent networks Media node broadcast opinion sweep Default values for all other parameters Media Node 87
88 Multi-Factor Sensitivity Analysis Analyze effect of multiple uncertain inputs on output values Sensitivity Index measures effect of inputs on output A Input Sensitivity Index B A 0.5 B 0.3 C C
Tobacco-Control Policy Workshop:
Tobacco-Control Policy Workshop: Goal: to introduce Mega-Country leaders to an effective policy framework for tobacco control and to develop skills to promote policy implementation. Objectives: As a result
More informationTobacco Surveillance in the United States
Tobacco Surveillance in the United States Gary Giovino Roswell Park Cancer Institute National Conference on Tobacco OR Health San Francisco, California November 20, 2002 Outline of Presentation Public
More informationTobacco Surveillance in the United States
Tobacco Surveillance in the United States Gary Giovino Roswell Park Cancer Institute National Conference on Tobacco OR Health Boston, Massachusetts December 10, 2003 Outline of Presentation Public health
More informationHow to Regulate E-Cigarettes? Are we asking the right questions?
How to Regulate E-Cigarettes? Are we asking the right questions? Eric N. Lindblom Director, Tobacco Control and Food & Drug Law O Neill Institute for National & Global Health Law Georgetown University
More informationUNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products
UNITED STATES REGULATION OF TOBACCO PRODUCTS Presented by Mitch Zeller Center Director FDA Center for Tobacco Products May 24, 2016 OVERVIEW OF TODAY S PRESENTATION Highlights of the Deeming Final Rule
More informationWHO Framework Convention on Tobacco Control
WHO Framework Convention on Tobacco Control When WHO was established in 1948, its Member States incorporated the power to negotiate treaties into its Constitution. This power remained dormant until 1996,
More informationACHIEVING SMOKEFREE AOTEAROA BY2025
ACHIEVING SMOKEFREE AOTEAROA BY2025 Monitoring and evaluation plan CONTENTS Acknowledgements 1 Introduction 2 Logic model 3 Sources of information 4 Monitoring progress towards the SFA 2025 goal 4 System
More informationMitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association
Regulatory Public Laws Compliance & Education Policies Science & Enforcement & Communications The FDA Center for Tobacco Products (CTP): Its Role in Reducing Tobacco Use Mitch Zeller, Director, Center
More informationMDQuit Best Practices Conference January 26, Presented by William C. Tilburg Deputy Director
MDQuit Best Practices Conference January 26, 2017 Presented by William C. Tilburg Deputy Director Founded in 2001 Partnership between UM School of Law, DHMH, and Maryland Office of the Attorney General
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 23.11.2009 SEC(2009) 1621 final COMMISSION STAFF WORKING DOCUMENT Report on the implementation of the Council Recommendation of 2 December 2002 on the prevention
More informationMAPS ON GLOBAL TOBACCO CONTROL POLICY DATA
APPENDIX XII: MAPS ON GLOBAL TOBACCO CONTROL POLICY DATA Appendix XII provides global overview maps on monitoring tobacco prevalence, smoke-free environments, treatment of tobacco dependence, health warnings
More informationFDA Center for Tobacco Products: Tobacco Research and the Population Assessment of Tobacco and Health (PATH) Study
FDA Center for Tobacco Products: Tobacco Research and the Population Assessment of Tobacco and Health (PATH) Study Regulatory Public Laws Compliance & Education Policies Science & Enforcement & Communications
More informationThe cost-effectiveness of raising the legal smoking age in California Ahmad S
The cost-effectiveness of raising the legal smoking age in California Ahmad S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each
More informationEvaluating Interventions to Curb ENDS Use Among Utah Youth
Evaluating Interventions to Curb ENDS Use Among Utah Youth CDC CC Grant 2016-2017 Braden Ainsworth, MPH, Utah Department of Health Claudia Bohner, MPH, Utah Department of Health Erik Crankshaw, PhD, RTI
More informationReducing Tobacco Use and Secondhand Smoke Exposure: Interventions to Increase the Unit Price for Tobacco Products
Reducing Tobacco Use and Secondhand Smoke Exposure: Interventions to Increase the Unit Price for Tobacco Products Task Force Finding and Rationale Statement Table of Contents Intervention Definition...
More informationUnderstanding the Tobacco Control Act
Understanding the Tobacco Control Act An Overview of the Tobacco Control Act and Center for Tobacco Products for the National Native Network CAPT Gail Cherry-Peppers, Tribal Liaison Heather Althouse, Senior
More informationUPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY
UPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY Presented by Ii-Lun Chen, M.D Director Division of Individual Health Science Office of Science, CTP, FDA Disclaimer: This is not a formal dissemination
More informationCountry profile. Nepal
WHO Report on the Global Tobacco Epidemic, 2013 Country profile Nepal WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 3 December 2003 Date of ratification (or legal equivalent)
More informationREGULATORY OPTIONS FOR MOVING TO THE ELIMINATION OF SMOKING. Ron Borland PhD
REGULATORY OPTIONS FOR MOVING TO THE ELIMINATION OF SMOKING Ron Borland PhD Tobacco Smoking Extremely harmful to health Kills over half of long-term users Reduces quality life years in most Slows recovery
More informationRADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS
Ending the Tobacco Epidemic RADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS Tim McAfee, MD, MPH Senior Medical Officer, Office on Smoking and Health, CDC www.nwcphp.org/hot-topics
More informationCountry profile. Timor-Leste
WHO Report on the Global Tobacco Epidemic, 2013 Country profile Timor-Leste WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 25 May 2004 Date of ratification (or legal equivalent)
More information- Decree nº (January 2 nd, 2006) Promulgates the Framework Convention on Tobacco Control
Brazilian Federal Legislation on Tobacco Control 3.1.1 General obligations - Decree (August 1 st, 2003) Creates the National Commission for the Implementation of the Framework Convention on Tobacco Control.
More informationCountry profile. Myanmar
WHO Report on the Global Tobacco Epidemic, 2013 Country profile Myanmar WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 23 October 2003 Date of ratification (or legal equivalent)
More informationTexas Bill to Regulate Vapor Products. Over the past few years, electronic cigarettes, also commonly referred to as e-cigarettes
Texas Bill to Regulate Vapor Products Over the past few years, electronic cigarettes, also commonly referred to as e-cigarettes or vapor, have been trending all over the state of Texas as a tobacco alternative,
More informationThe Latest on Vaping Among U.S. Teens
The Latest on Vaping Among U.S. Teens Jon Macy, PhD, MPH Indiana University School of Public Health Bloomington Presentation Outline Overview of Electronic Nicotine Delivery Systems (ENDS) New Prevalence
More informationRegulatory Options for State Cannabis Legalization: What Prevention Needs to Know
Regulatory Options for State Cannabis Legalization: What Prevention Needs to Know Raanan Kagan Director, Health Policy Research Carnevale Associates, LLC Josh Esrick, MA Senior Policy Analyst, Carnevale
More informationELEVEN REASONS WHY S IS BAD PUBLIC POLICY. Clinton Admin. FY00 budget request for FDA tobacco regulation was $34 million.
ELEVEN REASONS WHY S. 2461 IS BAD PUBLIC POLICY 1. Creates New Bureaucracy. Clinton Admin. FY00 budget request for FDA tobacco regulation was $34 million. S.2461 includes a tax increase of $300 million
More informationProblem Which option Additional option Additional comments definition Yes No change No further observations.
Department of Health, United Kingdom electronic contribution rec. 317 - by Mr Lee McGill lee.mcgill@dh.gsi.gov.uk Question 1 - scope Problem Which option Recommend option Additional comments Yes No change
More informationACTION PLAN. Intergovernmental Coordinating Body, Ministry of Finance. Intergovernmental Coordinating Body, Ministry of Finance
ACTION PLAN Strategic goal 1: Reduction of tobacco demand which should reduce the prevalence of smoking in the population Objectives Activity/Action Responsible Party/Implementing Body Deadline Source
More informationLAW OF MONGOLIA. 01 July, Ulaanbaatar, Mongolia LAW ON TOBACCO CONTROL CHAPTER ONE GENERAL PROVISIONS
LAW OF MONGOLIA 01 July, 2005. Ulaanbaatar, Mongolia LAW ON TOBACCO CONTROL Article 1: The Purpose Of The Law CHAPTER ONE GENERAL PROVISIONS 1.1 The purpose of this law is to define the legal framework
More informationSelected Agent Characteristics. Product type Nicotine dose levels Constituents (e.g., tar, CO) and ingredients (e.g., additives) Market share
Tobacco Measurement Stephen Marcus, Ph.D. Tobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences Public Health Model Agent -- tobacco products
More informationREPORT ON GLOBAL YOUTH TOBACCO SURVEY SWAZILAND
REPORT ON GLOBAL YOUTH TOBACCO SURVEY 2009 - SWAZILAND Introduction The tobacco epidemic Tobacco use is considered to be the chief preventable cause of death in the world. The World Health Organization
More informationTobacco Free Ireland Action Plan
Tobacco Free Ireland Action Plan Tobacco Free Ireland, the report of the Tobacco Policy Review Group, was endorsed by Government, and published in October 2013. It builds on existing tobacco control policies
More informationAn Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018
An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis February 2018 I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize,
More informationTobacco Surveillance and Evaluation: An Update
Tobacco Surveillance and Evaluation: An Update Gary A. Giovino, PhD, MS University at Buffalo School of Public Health and Health Professions Overview! Conceptual models of surveillance/evaluation! Relevant
More informationCDC and Bridging the Gap: Introducing New State Appropriation, Grants, and Expenditure Data in the STATE System
CDC and Bridging the Gap: Introducing New State Appropriation, Grants, and Expenditure Data in the STATE System Frank Chaloupka, PhD (University of Illinois-Chicago) Jidong Huang, PhD (University of Illinois-Chicago)
More informationELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?
ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE? E-cigarettes have the potential to benefit adult smokers who are not pregnant if used as a complete substitute for regular cigarettes and other smoked tobacco
More informationMinisterial Round Table: Accelerating implementation of WHO FCTC in SEAR
REGIONAL COMMITTEE Provisional Agenda item 14.3 Sixty-eighth Session SEA/RC68/28 Dili, Timor-Leste 7 11 September 2015 20 July 2015 Ministerial Round Table: Accelerating implementation of WHO FCTC in SEAR
More informationAn Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis
An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize, regulate
More informationSocial and Policy Perspective on Tobacco Use
Social and Policy Perspective on Tobacco Use Kenneth E. Warner University of Michigan School of Public Health National Cancer Policy Forum Workshop on Reducing Tobacco-Related Cancer Incidence and Mortality
More informationTOBACCO TAXATION, TOBACCO CONTROL POLICY, AND TOBACCO USE
TOBACCO TAXATION, TOBACCO CONTROL POLICY, AND TOBACCO USE Frank J. Chaloupka Director, ImpacTeen, University of Illinois at Chicago www.uic.edu/~fjc www.impacteen.org The Fact is, Raising Tobacco Prices
More informationRegulatory Support for Tobacco Products. Feeling daunted by the regulatory process for tobacco products? Don t worry Battelle can help.
Regulatory Support for Tobacco Products Feeling daunted by the regulatory process for tobacco products? Don t worry Battelle can help. PREMARKET TOBACCO (PMTA) HUMAN FACTORS STUDIES SUBSTANTIAL EQUIVALENCE
More informationSocial and Behavioral Sciences for Tobacco Use
Social and Behavioral Sciences for Tobacco Use Bonnie L. Halpern-Felsher, Ph.D., FSAHM Professor Division of Adolescent Medicine Department of Pediatrics Tobacco Decision-Making Theoretical Framework Demographic
More informationLebanon s Tobacco Control Policy: Opportunities and Gaps
Lebanon s Tobacco Control Policy: Opportunities and Gaps May 11, 2013 The 46 th Middle East Medical Assembly American University of Beirut Rima Nakkash, DrPH Assistant Professor Coordinator- AUB Tobacco
More information5,000. Number of cigarettes 4,000 3,000 2,000 1,000
A HISTORY of TOBACCO CONTROL EFFORTS UNDERSTANDING the ROLE of TOBACCO in the NEW WORLD Tobacco use originated in the Americas and was exported worldwide. Once tobacco became a popular crop throughout
More informationMarijuana Legalization Public Health Considerations & Municipal Options
Marijuana Legalization Public Health Considerations & Municipal Options This brief provides the potential public health impact of increased access to marijuana based on experiences of states that have
More informationGATS Highlights. GATS Objectives. GATS Methodology
GATS Objectives GATS Highlights The Global Adult Tobacco Survey (GATS) is a global standard for systematically monitoring adult tobacco use (smoking and smokeless) and tracking key tobacco control indicators.
More informationYouth Possession Laws: Promising Approach Or Diversion?
Youth Possession Laws: Promising Approach Or Diversion? Prepared for the 6 th National Synar Workshop March 13, 2002 ImpacTeen and YES! are part of Bridging the Gap: Research Informing Practice for Healthy
More informationCountry profile. Lebanon
WHO Report on the Global Tobacco Epidemic, 2013 Country profile Lebanon WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 4 March 2004 Date of ratification (or legal equivalent)
More informationTobacco Control in Ukraine. Second National Report. Kyiv: Ministry of Health of Ukraine p.
Tobacco Control in Ukraine. Second National Report. Kyiv: Ministry of Health of Ukraine. 2014. 128 p. This document has been produced with the help of a grant from the World Lung Foundation. The contents
More informationFDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality
FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality Lawrence Deyton, M.S.P.H., M.D. Director, FDA Center for Tobacco Products June 11, 2012 FDA s Vision To make tobaccorelated
More informationPeter G. Shields, MD Tobacco Products Scientific Advisory Committee (TPSAC) August 16, 2013
Peter G. Shields, MD Tobacco Products Scientific Advisory Committee (TPSAC) August 16, 2013 Conceptual Framework for Evaluating MRTPs: Objectives Provide a framework for evaluating all tobacco products
More informationComplex Adaptive Systems Engineering - improving our understanding of complex systems and reducing their risk
System of Systems (CASoS) System Engineering of Systems Engineering Initiative http://www.sandia.gov/casosengineering/ Systems Engineering - improving our understanding of complex systems and reducing
More informationKey Elements of this Presentation. Smoking Still Main Cause of Premature Death 31/10/2013. The Case for Plain Packaging
The Case for Plain Packaging Gerry McElwee Head of Cancer Prevention Key Elements of this Presentation Why smoking is still a priority for public health Why we need plain packaging Tobacco industry myths
More informationE-Cigarettes: A Game Changer. Dr. Blake Brown Hugh C. Kiger Professor Agriculture and Resource Economics College of Agriculture & Life Sciences
E-Cigarettes: A Game Changer Dr. Blake Brown Hugh C. Kiger Professor Agriculture and Resource Economics College of Agriculture & Life Sciences What is an e-cigarette? Battery Cartridge Indicator Light
More informationTobacco Product Regulation: FDA s Economic Impact Analysis Frank J. Chaloupka University of Illinois at Chicago
Tobacco Product Regulation: FDA s Economic Impact Analysis Frank J. Chaloupka University of Illinois at Chicago American Heart Association/American Stroke Association Advocacy Coordinating Committee Dallas
More informationPrevent disease Protect from injury Promote healthy lifestyles
https://youtu.be/9dzs_rniak0 Prevent disease Protect from injury Promote healthy lifestyles Objectives 1. Obtain a better understanding of local policies that make a difference 2. Establish a plan of action
More informationEXECUTIVE SUMMARY. 1 P age
EXECUTIVE SUMMARY The Global Adult Tobacco Survey (GATS) is the global standard for systematically monitoring adult tobacco use (smoking and smokeless) and tracking key tobacco control indicators. GATS
More informationCountry profile. Switzerland
Country profile Switzerland WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 25 June 2004 Date of ratification (or legal equivalent) t ratified Socioeconomic context Population
More informationCountry profile. Cuba
Country profile Cuba WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 29 June 2004 Date of ratification (or legal equivalent) t ratified Socioeconomic context Population
More informationNYS Conference of Environmental Health Directors Meeting October 28, 2014
NYS Conference of Environmental Health Directors Meeting October 28, 2014 Bureau of Community Environmental Health and Food Protection Director: Brian M. Miner Discussion Topic: Smoking Restrictions ATUPA
More informationCountry profile. Senegal
Country profile Senegal WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 19 June 2003 Date of ratification (or legal equivalent) 27 January 2005 Socioeconomic context Population
More informationEvaluation of Tobacco Control Programs: ASSIST
Evaluation of Tobacco Control Programs: ASSIST Frances Stillman, EdD Institute for Global Tobacco Control Johns Hopkins Bloomberg School of Public Health Section A Overview of ASSIST 1 American Stop Smoking
More informationapply to all products sold in the country
Report of Advocacy Workshop on Warning against dangers of tobacco: Packaging and Labelling, 25-26 April, 2013, University of Public Health, Yangon, Myanmar Background According to the Article 11 of the
More informationCountry profile. Gambia
Country profile Gambia WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 16 June 2003 Date of ratification (or legal equivalent) 18 September 2007 Socioeconomic context Population
More informationCountry profile. Angola
Country profile Angola WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 29 June 2004 Date of ratification (or legal equivalent) 20 September 2007 Socioeconomic context Population
More informationLao People's Democratic Republic
Country profile Lao People's Democratic Republic WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 29 June 2004 Date of ratification (or legal equivalent) 6 September 2006
More informationRAISING THE TOBACCO SALE AGE TO 21: BUILDING STRONG ENFORCEMENT INTO THE LAW
RAISING THE TOBACCO SALE AGE TO 21: BUILDING STRONG ENFORCEMENT INTO THE LAW Raising the minimum legal sale age of tobacco products to 21 (Tobacco 21) is an important, emerging policy strategy to reduce
More informationSubmission to the World Health Organization on the Global Tobacco Control Committee
Submission to the World Health Organization on the Global Tobacco Control Committee Massachusetts Coalition For a Healthy Future Gregory N. Connolly, D.M.D., M.P.H. 250 Washington Street, 4 th Floor Boston,
More informationCountry profile. Yemen
Country profile Yemen WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 20 June 2003 Date of ratification (or legal equivalent) 22 February 2007 Socioeconomic context Population
More informationCommunity Capacity Building: Community Driven Efforts that Combat Tobacco Transnationals in our Communities and Abroad. Case Study
Community Capacity Building: Community Driven Efforts that Combat Tobacco Transnationals in our Communities and Abroad Case Study ABSTRACT The San Francisco Tobacco-Free Project has funded a number of
More informationCountry profile. Turkmenistan. WHO Framework Convention on Tobacco Control (WHO FCTC) status. Date of ratification (or legal equivalent) 13 May 2011
Country profile Turkmenistan WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature t signed Date of ratification (or legal equivalent) 13 May 2011 Socioeconomic context Population
More informationMessage From the Minister
May 2002 Message From the Minister A basic principle of the health and social services system is that people have a responsibility to maintain their own health. The Department of Health and Social Services
More informationU.S. House of Representatives U.S. Senate. U.S. House of Representatives U.S. Senate
Harold P. Wimmer National President and CEO December 6, 2017 The Honorable Paul Ryan The Honorable Mitch McConnell Speaker Majority Leader U.S. House of Representatives U.S. Senate H-232, The Capitol S-230,
More informationGuideline for Advertising of e-cigarettes
GUIDELINE 43 Guideline for Advertising of e-cigarettes Last Updated May 2015 What kind of product is this guideline for? What is the purpose of this guideline? Electronic, or e-cigarettes, are battery
More informationCountry profile. Austria
Country profile Austria WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 28 August 2003 Date of ratification (or legal equivalent) 15 September 2005 Socioeconomic context
More informationTOBACCO PRODUCT OR MEDICAL PRODUCT?
TOBACCO PRODUCT OR MEDICAL PRODUCT? Priscilla Callahan-Lyon, MD Deputy Director Division of Individual Health Science Office of Science, CTP Grail Sipes, JD Director Office of Regulatory Policy, CDER Disclaimer:
More informationLAW OF MONGOLIA. 01 July 2005 Ulaanbaatar city ON TOBACCO CONTROL. (revised) CHAPTER ONE GENERAL PROVISIONS
Unofficial Translation LAW OF MONGOLIA 01 July 2005 Ulaanbaatar city Article 1. The Purpose of the Law ON TOBACCO CONTROL (revised) CHAPTER ONE GENERAL PROVISIONS 1.1. The purpose of this Law is to define
More informationBosnia and Herzegovina
Country profile Bosnia and Herzegovina WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature t signed Date of ratification (or legal equivalent) 10 July 2009 Socioeconomic context
More informationCountry profile. Republic of Moldova
Country profile Republic of Moldova WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 29 June 2004 Date of ratification (or legal equivalent) 3 February 2009 Socioeconomic
More informationTobacco Use: Epidemiology and Determinants Andrea Villanti, PhD, MPH Vermont Center on Behavior and Health University of Vermont November 1, 2017
Tobacco Use: Epidemiology and Determinants Andrea Villanti, PhD, MPH Vermont Center on Behavior and Health University of Vermont November 1, 2017 2 1 What is public health? Public health promotes and protects
More informationPlanning For The FDA s 'Deeming Rule' For E- Cigarettes
Law360, New York (September 21, 2015, 3:39 PM ET) -- The 2009 Family Smoking Prevention and Tobacco Control Act (TCA)[1] gave the U.S. Food and Drug Administration the authority to oversee the manufacture,
More information22nd Century Group, Inc. (XXII - $ Buy) Q1 Far Ahead of Expectations
Company Update Industrial & Consumer Technology 22nd Century Group, Inc. (XXII - $2.21 - Buy) COMPANY NOTE Estimate Change JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com
More informationThe Economics of tobacco and other addictive goods Hurley, pp
s of The s of tobacco and other Hurley, pp150 153. Chris Auld s 318 March 27, 2013 s of reduction in 1994. An interesting observation from Tables 1 and 3 is that the provinces of Newfoundland and British
More informationTOBACCO PLAYBOOK DÉJÀ VU: E-CIGARETTES MICHIGAN CANCER CONSORTIUM MARCH 26, 2014
TOBACCO PLAYBOOK DÉJÀ VU: E-CIGARETTES MICHIGAN CANCER CONSORTIUM MARCH 26, 2014 WHAT IS AN ELECTRONIC CIGARETTE? o Allows user to inhale vapor containing nicotine and/or other substances. o Disposable
More informationPublic Health England s Independent Expert E-Cigarettes Evidence Review
Public Health England s Independent Expert E-Cigarettes Evidence Review Misinformation, Misreporting and Public Understanding Ann McNeill Contents 1. PHE e-cigarette evidence updates 2. Public understanding
More informationElectronic Cigarettes: What They Are, How They re Marketed, & How We Can Protect Our Youth
Electronic Cigarettes: What They Are, How They re Marketed, & How We Can Protect Our Youth Amy Barkley Coalition for a Tobacco- Free West Virginia Charleston, WV February 26, 2014 Big Picture Points Tobacco
More informationWHO FCTC: Text, Commitments, and Timelines: Gemma Vestal, JD, MPH, MBA, BSN. Article 15: Illicit Trade in Tobacco Products
Section B Supply Reduction: Articles 15 17 Article 15: Illicit Trade in Tobacco Products This area is one in which country-level efforts are necessary, but insufficient due to the transnational nature
More informationPredicting the population health effects of changing tobacco exposures: Statistical models for regulatory compliance
Predicting the population health effects of changing tobacco exposures: Statistical models for regulatory compliance NASEM ENDS Workshop February 2017 Annette M. Bachand, Ph.D. Goal of Statistical Models:
More informationProgress toward quitting. The cessation environment in New York
Progress toward quitting The cessation environment in New York TCP Vision and Mission Vision: All New Yorkers live in a tobacco free society. Mission: Reduce morbidity and mortality and alleviate social
More informationSMOKING BEHAVIOUR OF CZECH ADOLESCENTS: RESULTS OF THE GLOBAL YOUTH TOBACCO SURVEY IN THE CZECH REPUBLIC, 2002
Cent Eur J Publ Health 2004; 12 (1): 26-31 SMOKING BEHAVIOUR OF CZECH ADOLESCENTS: RESULTS OF THE GLOBAL YOUTH TOBACCO SURVEY IN THE CZECH REPUBLIC, 2002 Sovinová H. 1, Csémy L. 2 1 National Institute
More informationFDA s Response to the Opioid Crisis and the FDA Safe Use Initiative
FDA s Response to the Opioid Crisis and the FDA Safe Use Initiative Scott K. Winiecki, MD Professional Affairs and Stakeholder Engagement Staff (PASES) Center For Drug Evaluation and Research (CDER) U.S.
More informationTOBACCO INDUSTRY MONITORING TOOL
TOBACCO INDUSTRY MONITORING TOOL CTCA MakSPH 1 Centre for Tobacco Control in Africa (CTCA) Library Cataloguing - in Publication Data Supporting African governments to build and sustain capacity for tobacco
More informationCountry profile. Trinidad and Tobago
Country profile Trinidad and Tobago WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 27 August 2003 Date of ratification (or legal equivalent) 19 August 2004 Socioeconomic
More informationCountry profile. Poland
Country profile Poland WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 14 June 2004 Date of ratification (or legal equivalent) 15 September 2006 Socioeconomic context Population
More informationCountry profile. Bahrain. WHO Framework Convention on Tobacco Control (WHO FCTC) status. Date of ratification (or legal equivalent) 20 March 2007
Country profile Bahrain WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature t signed Date of ratification (or legal equivalent) 20 March 2007 Socioeconomic context Population
More informationTobacco-related risk perceptions in the regulation of tobacco products at the FDA Center for Tobacco Products
Tobacco-related risk perceptions in the regulation of tobacco products at the FDA Center for Tobacco Products David B. Portnoy, PhD, MPH Conrad J. Choiniere, PhD Office of Science FDA, Center for Tobacco
More informationCountry profile. Chad
Country profile Chad WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 22 June 2004 Date of ratification (or legal equivalent) 30 January 2006 Socioeconomic context Population
More informationCountry profile. Hungary
Country profile Hungary WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 16 June 2003 Date of ratification (or legal equivalent) 7 April 2004 Socioeconomic context Population
More information